<qa>  What is allowed to be confirmed by histologically confirmed recurrent or metastatic carcinoma- Histologically confirmed recurrent or metastatic carcinoma of the nasopharynx is allowed, but these participants will not be included as response-evaluable participants for efficacy analysis of HNSCC. 